EU Makes Only Limited Use Of Remote Clinical Trial Monitoring
While regulators worldwide are opening up to the possibility of remote verification of source data from clinical trial sites because of COVID-19 restrictions, this approach is finding less favor in the EU, mainly because of strict data protection rules.
You may also be interested in...
The COVID-19 pandemic has given a new impetus to Sweden’s ongoing efforts to support decentralized clinical trials.
A senior official from the European Medicines Agency says the COVID-19 pandemic has changed the future clinical trials landscape for good.
Updated UK guidance describes the factors that clinical trial sponsors and investigator sites must consider when giving appointed representatives direct access to the electronic health records of participants in clinical trials to check source data.